Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

NCT00824135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Clofarabine
PROCEDURE: Stem Cell Transplantation, Hematopoietic
OTHER: OKT3
DRUG: Thiotepa
DRUG: Melphalan
DRUG: Mycophenolate mofetil
DRUG: Rituximab
OTHER: G-CSF

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]